These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16514112

  • 1. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]

  • 2. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan 01; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 4. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
    Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, Ogawa K, Inoue Y.
    BMJ Open Respir Res; 2019 Jan 01; 6(1):e000434. PubMed ID: 31258920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Zweijpfenning SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, Stemkens R, Geurts B, van Ingen J, Hoefsloot W.
    Chest; 2024 May 01; 165(5):1082-1092. PubMed ID: 38040054
    [Abstract] [Full Text] [Related]

  • 7. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb 01; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 8. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
    Kobashi Y, Oka M.
    Kekkaku; 2008 Dec 01; 83(12):779-84. PubMed ID: 19172823
    [Abstract] [Full Text] [Related]

  • 9. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis.
    Ku JH, Henkle E, Carlson KF, Marino M, Brode SK, Marras TK, Winthrop KL.
    Chest; 2024 May 01; 165(5):1058-1069. PubMed ID: 38086472
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP, Laurenson IF, Hill AT.
    Clin Infect Dis; 2008 Jul 15; 47(2):222-4. PubMed ID: 18532890
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
    Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A.
    Chest; 2009 Dec 15; 136(6):1569-1575. PubMed ID: 19542259
    [Abstract] [Full Text] [Related]

  • 12. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Koh WJ, Jeong BH, Jeon K, Park HY, Kim SY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL.
    Antimicrob Agents Chemother; 2015 Aug 15; 59(8):4994-6. PubMed ID: 25987622
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

  • 14. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul 15; 6(7):628-34. PubMed ID: 12102303
    [Abstract] [Full Text] [Related]

  • 15. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH, Jeon K, Park HY, Moon SM, Kim SY, Lee SY, Shin SJ, Daley CL, Koh WJ.
    Antimicrob Agents Chemother; 2016 Oct 15; 60(10):6076-83. PubMed ID: 27480854
    [Abstract] [Full Text] [Related]

  • 16. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 15; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 17. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
    Kobashi Y, Matsushima T, Oka M.
    Respir Med; 2007 Jan 15; 101(1):130-8. PubMed ID: 16750618
    [Abstract] [Full Text] [Related]

  • 18. [Perspective of pulmonary MAC infection treatment].
    Kurashima A.
    Kekkaku; 2007 Mar 15; 82(3):195-9. PubMed ID: 17444124
    [Abstract] [Full Text] [Related]

  • 19. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F.
    Am J Respir Crit Care Med; 1999 Sep 15; 160(3):866-72. PubMed ID: 10471610
    [Abstract] [Full Text] [Related]

  • 20. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
    Tanaka E.
    Kekkaku; 1996 Sep 15; 71(9):547-9. PubMed ID: 8999140
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.